TI
PCVX icon

Tidal Investments’s Vaxcyte PCVX Stock Holding History

Tidal Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,397
Closed -$408K – 1939
2024
Q2 		$408K Sell
5,397
-531
-9% -$36.1K 0.01% 1402
2024
Q1 		$405K Buy
+5,928
New +$410K 0.01% 1274

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tidal Investments's PCVX Position: Q3 2024 in Review

Tidal Investments sold out of Vaxcyte (PCVX) in Q3 2024, closing a stake of 5,397 shares — an estimated $408K sold.

Tidal Investments first reported a position in PCVX in Q1 2024 and held it in 2 quarters. The position peaked at $408K in Q2 2024. 328 funds tracked by Wall St. Rank hold PCVX as of Q3 2024.

  • Tidal Investments reported no remaining Vaxcyte position as of Q3 2024 after selling out during the quarter.
  • Tidal Investments sold 5,397 Vaxcyte shares in Q3 2024, an estimated $408K.
  • Tidal Investments first reported a position in Vaxcyte in Q1 2024 and held it in 2 quarters.
  • Tidal Investments's Vaxcyte position peaked at $408K in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2024.

Based on Tidal Investments's 13F filing for Q3 2024, filed 14 Nov 2024.